1. Comparison of the average surviving fraction model with the integral biologically effective dose model for an optimal irradiation scheme
   Ryo Takagi et al, 2018, Journal of Radiation Research CrossRef
2. Three‐dimensional conformal radiation therapy for inoperable massive hepatocellular carcinoma in six dogs
   T. Mori et al, 2015, Journal of Small Animal Practice CrossRef
3. Use of Radiotherapy Alone and in Combination with Other Therapies for Hepatocellular Carcinoma: Rationale and Future Directions
   Dan G. Duda et al, 2022, The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases CrossRef
4. Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells
   ZHIXIONG LONG et al, 2014, International Journal of Molecular Medicine CrossRef
5. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy
   Yoshiro Matsuo et al, 2016, Journal of Radiation Research CrossRef
6. Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care
   Alejandra Méndez Romero et al, 2016, Best Practice & Research Clinical Gastroenterology CrossRef
7. The Role of Radiotherapy and Chemoradiation in the Management of Primary Liver Tumours
   K.L. Aitken et al, 2014, Clinical Oncology CrossRef
8. Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition)
   Shuqun Cheng et al, 2020, Liver Cancer CrossRef
9. Triplet regimen as a novel modality for advanced unresectable hepatocellular carcinoma: A case report and review of literature
   Ying Zhao et al, 2023, World Journal of Clinical Cases CrossRef